Ethan R. Goldman

Davis Polk advised the representatives of the underwriters in connection with the $511.5 million SEC-registered offering of 5,500,000 American Depositary Shares of BioNTech SE. In addition,…

Davis Polk advised the joint book-running managers on an offering by Wyndham Destinations, Inc. of $650 million aggregate principal amount of its 6.625% senior secured notes due…

Davis Polk advised JHSF Participações S.A. in connection with the equity offering by JHSF Participações and a selling shareholder of 44,427,950 common shares for an aggregate amount of R…

Davis Polk advised GHK Capital Partners LP on its acquisition of Hasa, Inc. and the related financing arrangements. Davis Polk also advised GHK Capital on its arrangements with co-investors…

Davis Polk advised the joint book-running managers and the initial purchasers in Rule 144A/Regulation S offerings of €325 million principal amount of 2.750% senior secured notes due 2028…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Abbott Laboratories of $650 million aggregate principal amount of 1.150% notes due 2028 and $650…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $124.7 million SEC-registered offering of 28,503,220 shares of…

Davis Polk advised the dealer manager in connection with a cash tender offer by Aviation Capital Group LLC to purchase any and all of its outstanding 7.125% notes due 2020. Aviation…

Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 5,980,000 shares of common stock of ChemoCentryx, Inc. (which…

Davis Polk advised the underwriters on an SEC-registered offering by BankUnited, Inc. of $300 million aggregate principal amount of 5.125% subordinated notes due 2030.BankUnited, Inc…